ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,956 | +42.2% | 1,294 | +100.0% | 0.00% | – |
| Q2 2023 | $18,249 | -32.4% | 647 | -32.7% | 0.00% | – |
| Q2 2022 | $27,000 | -47.1% | 962 | -13.5% | 0.00% | – |
| Q1 2022 | $51,000 | -50.0% | 1,112 | -8.7% | 0.00% | – |
| Q4 2021 | $102,000 | +1357.1% | 1,218 | +1082.5% | 0.00% | – |
| Q3 2021 | $7,000 | – | 103 | +1371.4% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 7 | -99.5% | 0.00% | – |
| Q3 2020 | $43,000 | -10.4% | 1,305 | +30.5% | 0.00% | – |
| Q2 2020 | $48,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |